Post-PCI FFR in Multivessel Disease Predicts Target Vessel Failure
In a new analysis of the FAME 3 trial, post-PCI fractional flow reserve predicted both target vessel failure and the risk of cardiac events.
Source: medscape.com
Stay updated with breaking news from Eneric Dr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a new analysis of the FAME 3 trial, post-PCI fractional flow reserve predicted both target vessel failure and the risk of cardiac events.